Prot# CL-01-0303: Phase IIb Multicenter Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Advanced Cutaneous T-Cell Lymphoma (Merck Prot# 001-02)

  • Kuzel, Timothy Michael (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date8/11/04 → 9/11/06

Funding

  • Merck & Co., Inc. (CL-01-0303)